162 related articles for article (PubMed ID: 1858377)
1. [Repeat mass screening for fecal occult blood for the diagnosis of colorectal neoplasms in a rural district. Results of an informational campaign].
Hofbauer F; Mach K; Egermann G
Wien Klin Wochenschr; 1991; 103(10):288-95. PubMed ID: 1858377
[TBL] [Abstract][Full Text] [Related]
2. Results of screening for colorectal carcinoma in the District of Bruntál using the Haemoccult Test in 1985-1988.
Zoubek V; Zoubková H
Czech Med; 1990; 13(2-3):52-7. PubMed ID: 2245757
[TBL] [Abstract][Full Text] [Related]
3. Colorectal cancer screening through detection of fecal occult blood in a controlled health zone.
Tárraga P; García-Olmo D; Celada A; García-Molinero Mf; Divison JA; Casado C
Rev Esp Enferm Dig; 1999 May; 91(5):335-44. PubMed ID: 10362875
[TBL] [Abstract][Full Text] [Related]
4. A comparison of the immunochemical fecal occult blood test and total colonoscopy in the asymptomatic population.
Morikawa T; Kato J; Yamaji Y; Wada R; Mitsushima T; Shiratori Y
Gastroenterology; 2005 Aug; 129(2):422-8. PubMed ID: 16083699
[TBL] [Abstract][Full Text] [Related]
5. [Results of screening for colorectal carcinoma in the Bruntál District using the Haemoccult Test 1985-1986].
Zoubek V; Zoubková H
Cas Lek Cesk; 1989 Apr; 128(15):460-2. PubMed ID: 2736587
[TBL] [Abstract][Full Text] [Related]
6. Can quantification of faecal occult blood predetermine the need for colonoscopy in patients at risk for non-syndromic familial colorectal cancer?
Levi Z; Rozen P; Hazazi R; Vilkin A; Waked A; Maoz E; Birkenfeld S; Niv Y
Aliment Pharmacol Ther; 2006 Nov; 24(10):1475-81. PubMed ID: 17032281
[TBL] [Abstract][Full Text] [Related]
7. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics.
Allison JE; Sakoda LC; Levin TR; Tucker JP; Tekawa IS; Cuff T; Pauly MP; Shlager L; Palitz AM; Zhao WK; Schwartz JS; Ransohoff DF; Selby JV
J Natl Cancer Inst; 2007 Oct; 99(19):1462-70. PubMed ID: 17895475
[TBL] [Abstract][Full Text] [Related]
8. The first 2 years of colorectal cancer screening in Ferrara, Italy.
Matarese VG; Feo CV; Lanza G; Fusetti N; Carpanelli MC; Cataldo S; Cifalà V; Ferretti S; Gafà R; Marzola M; Montanari E; Palmonari C; Simone L; Trevisani L; Stockbrugger R; Gullini S
Eur J Cancer Prev; 2011 May; 20(3):166-8. PubMed ID: 21445018
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the sensitivity of an immunochemical fecal occult blood test for colorectal neoplasia.
Yoshinaga M; Motomura S; Takeda H; Yanagisawa Z; Ikeda K
Am J Gastroenterol; 1995 Jul; 90(7):1076-9. PubMed ID: 7611200
[TBL] [Abstract][Full Text] [Related]
10. Limitations of the faecal occult blood test in screening for colorectal cancer.
Delcò F; Sonnenberg A
Ital J Gastroenterol Hepatol; 1999 Mar; 31(2):119-26. PubMed ID: 10363196
[TBL] [Abstract][Full Text] [Related]
11. [Screening for colorectal carcinoma in the region surrounding the city of Frýdek-Místek between 1999 - 2001].
Urban O; Chalupa P; Reha J; Orhalmi J; Hájek A; Paiger K; Vasutová I; Garcic A; Bubeník B
Vnitr Lek; 2002 Oct; 48(10):962-5. PubMed ID: 16737146
[TBL] [Abstract][Full Text] [Related]
12. Results of a repeat television-advertised mass screening program for colorectal cancer using fecal occult blood tests.
McGarrity TJ; Long PA; Peiffer LP
Am J Gastroenterol; 1990 Mar; 85(3):266-70. PubMed ID: 2309678
[TBL] [Abstract][Full Text] [Related]
13. Colonoscopy: a review of its yield for cancers and adenomas by indication.
Rex DK
Am J Gastroenterol; 1995 Mar; 90(3):353-65. PubMed ID: 7872270
[TBL] [Abstract][Full Text] [Related]
14. Many participants in fecal occult blood test population screening have a higher-than-average risk for colorectal cancer.
Worthley DL; Smith A; Bampton PA; Cole SR; Young GP
Eur J Gastroenterol Hepatol; 2006 Oct; 18(10):1079-83. PubMed ID: 16957514
[TBL] [Abstract][Full Text] [Related]
15. A prospective multicenter evaluation of new fecal occult blood tests in patients undergoing colonoscopy.
Greenberg PD; Bertario L; Gnauck R; Kronborg O; Hardcastle JD; Epstein MS; Sadowski D; Sudduth R; Zuckerman GR; Rockey DC
Am J Gastroenterol; 2000 May; 95(5):1331-8. PubMed ID: 10811348
[TBL] [Abstract][Full Text] [Related]
16. [Problems in the early diagnosis and treatment of colorectal carcinoma and adenoma in the aged].
Zoubek V; Zoubková H; Mrůzek M
Vnitr Lek; 1990 Oct; 36(10):998-1001. PubMed ID: 2256262
[TBL] [Abstract][Full Text] [Related]
17. Colorectal cancer screening for the natural population of Beijing with sequential fecal occult blood test: a multicenter study.
Li S; Nie Z; Li N; Li J; Zhang P; Yang Z; Mu S; Du Y; Hu J; Yuan S; Qu H; Zhang T; Wang S; Dong E; Qi D
Chin Med J (Engl); 2003 Feb; 116(2):200-2. PubMed ID: 12775229
[TBL] [Abstract][Full Text] [Related]
18. [Evaluation of RPHA fecal occult blood test in screening for colorectal cancer].
Yu H
Zhonghua Zhong Liu Za Zhi; 1990 Mar; 12(2):108-10. PubMed ID: 2401172
[TBL] [Abstract][Full Text] [Related]
19. Comparative analysis of patients with clinically diagnosed colorectal cancer and those detected by mass screening.
Colorectal Cancer Cooperating Group, Beijing Society of Gastroenterology
Chin J Dig Dis; 2005; 6(1):26-30. PubMed ID: 15667555
[TBL] [Abstract][Full Text] [Related]
20. Identification of colorectal adenomas by a quantitative immunochemical faecal occult blood screening test depends on adenoma characteristics, development threshold used and number of tests performed.
Rozen P; Levi Z; Hazazi R; Waked A; Vilkin A; Maoz E; Birkenfeld S; Leshno M; Niv Y
Aliment Pharmacol Ther; 2009 Apr; 29(8):906-17. PubMed ID: 19183147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
